CMS has published its final rule for Medicare Advantage and Part D in 2026, outlining a series of regulatory updates aimed at strengthening consumer protections and improving care coordination across ...

The Centers for Medicare and Medicaid Services said it would not cover the medications under Medicare’s Part D coverage.

The Centers for Medicare & Medicaid Services April 4 finalized changes to the Medicare Advantage and prescription drug ...

GoodRx has streamlined the online prescription purchase process, launching the experience with employee-owned Midwestern supermarket retailer Hy-Vee.

Emrosi™ approved by FDA for the treatment of inflammatory lesions of rosacea in adults, with commercial launch underway; ...

The total net revenue for the year ended December 31, 2024 of approximately $11.7 million for prescription and non-prescription products, including license revenue, increased approximately 20% versus ...

Announced the acceptance of the New Drug Application (NDA) by the U.S. Food and Drug Administration (FDA) for OLC for the treatment of hyperphosphatemia in patients with CKD on dialysis. The FDA set a ...

Tariff policies are changing so rapidly that it can be hard to keep up. Here are all of President Donald Trump's proposed, ...

While Novartis holds a diversified product portfolio, there is some product concentration with its largest drugs, Entresto (close to 15% of sales) and Cosentyx (close to 10% of sales). Both drugs will ...

Medicare Part D offers prescription drug coverage, helping seniors afford medications. A new policy in 2025 will cap ...

GSK remains on fairly stable financial footing, with a debt/EBITDA ratio of 2.8 at the end of 2024 and Haleon taking on close to GBP 10 billion of GSK's debt in the 2022 divestment. With the improving ...

Medicare Part D is a crucial component of the U.S. healthcare system, offering vital prescription drug coverage to millions ...